JP2019508400A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508400A5 JP2019508400A5 JP2018540697A JP2018540697A JP2019508400A5 JP 2019508400 A5 JP2019508400 A5 JP 2019508400A5 JP 2018540697 A JP2018540697 A JP 2018540697A JP 2018540697 A JP2018540697 A JP 2018540697A JP 2019508400 A5 JP2019508400 A5 JP 2019508400A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- aminomethyl
- quinolin
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229910052805 deuterium Inorganic materials 0.000 claims 20
- 150000001875 compounds Chemical class 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 17
- 239000012453 solvate Substances 0.000 claims 17
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000006716 (C1-C6) heteroalkyl group Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 6
- 125000006747 (C2-C10) heterocycloalkyl group Chemical group 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- -1 pyrrolidinonyl Chemical group 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 5
- 229910052739 hydrogen Inorganic materials 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 101001043352 Homo sapiens Lysyl oxidase homolog 2 Proteins 0.000 claims 2
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000002950 monocyclic group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- UAXWFGJUBIDUNN-UHFFFAOYSA-N 2-(aminomethyl)-1h-quinolin-4-one Chemical class C1=CC=C2NC(CN)=CC(=O)C2=C1 UAXWFGJUBIDUNN-UHFFFAOYSA-N 0.000 claims 1
- OVWRCTGOHGFRHO-UHFFFAOYSA-N 2-(aminomethyl)-4-oxo-1H-quinoline-6-carboxamide Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)N OVWRCTGOHGFRHO-UHFFFAOYSA-N 0.000 claims 1
- FNXGBFAEEZXYOO-UHFFFAOYSA-N 2-(aminomethyl)-4-oxo-1H-quinoline-6-carboxylic acid Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)O FNXGBFAEEZXYOO-UHFFFAOYSA-N 0.000 claims 1
- MPGZNSXKQWZXLU-UHFFFAOYSA-N 2-(aminomethyl)-6-(1,3-oxazol-2-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1OC=CN=1 MPGZNSXKQWZXLU-UHFFFAOYSA-N 0.000 claims 1
- XECZQHYCVGKWEA-UHFFFAOYSA-N 2-(aminomethyl)-6-(1,3-thiazol-2-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1SC=CN=1 XECZQHYCVGKWEA-UHFFFAOYSA-N 0.000 claims 1
- ODRAPGSREWKVTJ-UHFFFAOYSA-N 2-(aminomethyl)-6-(1-methylpyrazol-4-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NN(C=1)C ODRAPGSREWKVTJ-UHFFFAOYSA-N 0.000 claims 1
- TUAVFWOMCSSZCO-UHFFFAOYSA-N 2-(aminomethyl)-6-(1-phenylpyrazol-4-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NN(C=1)C1=CC=CC=C1 TUAVFWOMCSSZCO-UHFFFAOYSA-N 0.000 claims 1
- DEVXQKXROYLUKD-UHFFFAOYSA-N 2-(aminomethyl)-6-(1-phenyltriazol-4-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1N=NN(C=1)C1=CC=CC=C1 DEVXQKXROYLUKD-UHFFFAOYSA-N 0.000 claims 1
- ZUHKPOKSRFUEBP-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-chloro-4-fluorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=C(C=C(C=C1)F)Cl ZUHKPOKSRFUEBP-UHFFFAOYSA-N 0.000 claims 1
- NPEYCZKYOGTROH-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-chlorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=C(C=CC=C1)Cl NPEYCZKYOGTROH-UHFFFAOYSA-N 0.000 claims 1
- MVQCIDJEEKZUFE-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-fluoro-4-methoxyphenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=C(C=C(C=C1)OC)F MVQCIDJEEKZUFE-UHFFFAOYSA-N 0.000 claims 1
- SISRRCMARUNFMA-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-fluorophenoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OC1=C(C=CC=C1)F SISRRCMARUNFMA-UHFFFAOYSA-N 0.000 claims 1
- WNVGOQQXBWFIQF-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-fluorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=C(C=CC=C1)F WNVGOQQXBWFIQF-UHFFFAOYSA-N 0.000 claims 1
- VFJCIWDYAYMBFG-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-methoxyethoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCCOC VFJCIWDYAYMBFG-UHFFFAOYSA-N 0.000 claims 1
- YSGCVSHGLJODHH-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-methylpropoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC(C)C YSGCVSHGLJODHH-UHFFFAOYSA-N 0.000 claims 1
- UVSUGBRVTWVHMM-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-methyltetrazol-5-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1N=NN(N=1)C UVSUGBRVTWVHMM-UHFFFAOYSA-N 0.000 claims 1
- GEQDUPJECREPAJ-UHFFFAOYSA-N 2-(aminomethyl)-6-(2-phenylethynyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C#CC1=CC=CC=C1 GEQDUPJECREPAJ-UHFFFAOYSA-N 0.000 claims 1
- YCJFLLHJHJTWRQ-UHFFFAOYSA-N 2-(aminomethyl)-6-(3,4-dihydro-2H-quinolin-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1CCCC2=CC=CC=C12 YCJFLLHJHJTWRQ-UHFFFAOYSA-N 0.000 claims 1
- GNKQAYVZMQVGKC-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-chlorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC(=CC=C1)Cl GNKQAYVZMQVGKC-UHFFFAOYSA-N 0.000 claims 1
- VESFMLHWGPRYMJ-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-fluoro-4-methoxyphenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC(=C(C=C1)OC)F VESFMLHWGPRYMJ-UHFFFAOYSA-N 0.000 claims 1
- BAZGYVCGKZQZQG-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-fluorophenoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OC1=CC(=CC=C1)F BAZGYVCGKZQZQG-UHFFFAOYSA-N 0.000 claims 1
- AHSDOEOKVPJJDU-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-fluorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC(=CC=C1)F AHSDOEOKVPJJDU-UHFFFAOYSA-N 0.000 claims 1
- SJZBEYRTLZKJBD-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-phenylprop-2-ynoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC#CC1=CC=CC=C1 SJZBEYRTLZKJBD-UHFFFAOYSA-N 0.000 claims 1
- ZAOIMXDVWDEKNK-UHFFFAOYSA-N 2-(aminomethyl)-6-(3-phenylprop-2-ynylamino)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NCC#CC1=CC=CC=C1 ZAOIMXDVWDEKNK-UHFFFAOYSA-N 0.000 claims 1
- BFZHIPRPTKPMKT-UHFFFAOYSA-N 2-(aminomethyl)-6-(4,4,4-trifluorobut-2-ynoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC#CC(F)(F)F BFZHIPRPTKPMKT-UHFFFAOYSA-N 0.000 claims 1
- MFQOWMLDWNDXHK-UHFFFAOYSA-N 2-(aminomethyl)-6-(4,4,4-trifluorobut-2-ynylamino)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NCC#CC(F)(F)F MFQOWMLDWNDXHK-UHFFFAOYSA-N 0.000 claims 1
- NMYGNOPYOJTRRX-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-chloro-2-fluorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=C(C=C(C=C1)Cl)F NMYGNOPYOJTRRX-UHFFFAOYSA-N 0.000 claims 1
- YSZBAXFBORHULX-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-chlorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC=C(C=C1)Cl YSZBAXFBORHULX-UHFFFAOYSA-N 0.000 claims 1
- AXLNYEKSECPCIK-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-fluorophenoxy)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OC1=CC=C(C=C1)F AXLNYEKSECPCIK-UHFFFAOYSA-N 0.000 claims 1
- BCXZEZPYTYWCCS-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-fluorophenyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC=C(C=C1)F BCXZEZPYTYWCCS-UHFFFAOYSA-N 0.000 claims 1
- SSIDKITWCCINRB-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-phenylpiperazin-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1CCN(CC1)C1=CC=CC=C1 SSIDKITWCCINRB-UHFFFAOYSA-N 0.000 claims 1
- RBYUWXBYAHDXSE-UHFFFAOYSA-N 2-(aminomethyl)-6-(4-phenylpyrazol-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1N=CC(=C1)C1=CC=CC=C1 RBYUWXBYAHDXSE-UHFFFAOYSA-N 0.000 claims 1
- IFTOOFBQCVZZSU-UHFFFAOYSA-N 2-(aminomethyl)-6-(5-methyl-2-oxopyridin-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1C(C=CC(=C1)C)=O IFTOOFBQCVZZSU-UHFFFAOYSA-N 0.000 claims 1
- LOVKDJINYYOZCB-UHFFFAOYSA-N 2-(aminomethyl)-6-(5-phenylmethoxypyridin-3-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC=C(C=1)OCC1=CC=CC=C1 LOVKDJINYYOZCB-UHFFFAOYSA-N 0.000 claims 1
- JMOYPAHMBAZICM-UHFFFAOYSA-N 2-(aminomethyl)-6-(benzylamino)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NCC1=CC=CC=C1 JMOYPAHMBAZICM-UHFFFAOYSA-N 0.000 claims 1
- KKGNLOPTMIHMOK-UHFFFAOYSA-N 2-(aminomethyl)-6-(prop-2-ynylamino)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NCC#C KKGNLOPTMIHMOK-UHFFFAOYSA-N 0.000 claims 1
- YSXPSFTVHSCXKN-UHFFFAOYSA-N 2-(aminomethyl)-6-(pyrrolidine-1-carbonyl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)N1CCCC1 YSXPSFTVHSCXKN-UHFFFAOYSA-N 0.000 claims 1
- MEWOAUHQJYSULF-UHFFFAOYSA-N 2-(aminomethyl)-6-(tetrazol-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1N=NN=C1 MEWOAUHQJYSULF-UHFFFAOYSA-N 0.000 claims 1
- HLFWKORBOWLYFM-UHFFFAOYSA-N 2-(aminomethyl)-6-(tetrazol-2-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1N=CN=N1 HLFWKORBOWLYFM-UHFFFAOYSA-N 0.000 claims 1
- CFEYFYHYGALQHZ-UHFFFAOYSA-N 2-(aminomethyl)-6-(triazol-1-yl)-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1N=NC=C1 CFEYFYHYGALQHZ-UHFFFAOYSA-N 0.000 claims 1
- MWVJTQOFZGTCKH-UHFFFAOYSA-N 2-(aminomethyl)-6-[(1-methylpyrazol-4-yl)amino]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC=1C=NN(C=1)C MWVJTQOFZGTCKH-UHFFFAOYSA-N 0.000 claims 1
- OMULZNUIDMTHAT-UHFFFAOYSA-N 2-(aminomethyl)-6-[(1-phenylpyrazol-4-yl)amino]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC=1C=NN(C=1)C1=CC=CC=C1 OMULZNUIDMTHAT-UHFFFAOYSA-N 0.000 claims 1
- MOFKKCVSTYXKRP-UHFFFAOYSA-N 2-(aminomethyl)-6-[(2-fluorophenyl)methoxy]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC1=C(C=CC=C1)F MOFKKCVSTYXKRP-UHFFFAOYSA-N 0.000 claims 1
- QOAUJPRHOBHEBO-UHFFFAOYSA-N 2-(aminomethyl)-6-[(3-fluorophenyl)methoxy]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC1=CC(=CC=C1)F QOAUJPRHOBHEBO-UHFFFAOYSA-N 0.000 claims 1
- KACCPYIZDICMLV-BXUZGUMPSA-N 2-(aminomethyl)-6-[(3R,4R)-3-fluoro-4-hydroxypyrrolidine-1-carbonyl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)N1C[C@H]([C@@H](C1)O)F KACCPYIZDICMLV-BXUZGUMPSA-N 0.000 claims 1
- KACCPYIZDICMLV-FZMZJTMJSA-N 2-(aminomethyl)-6-[(3S,4S)-3-fluoro-4-hydroxypyrrolidine-1-carbonyl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)N1C[C@@H]([C@H](C1)O)F KACCPYIZDICMLV-FZMZJTMJSA-N 0.000 claims 1
- NKWNKTMVEPUHOA-UHFFFAOYSA-N 2-(aminomethyl)-6-[(4-fluorophenyl)methoxy]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC1=CC=C(C=C1)F NKWNKTMVEPUHOA-UHFFFAOYSA-N 0.000 claims 1
- NIOJRGLZVLZTEC-UHFFFAOYSA-N 2-(aminomethyl)-6-[2-(2-fluorophenyl)ethynyl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C#CC1=C(C=CC=C1)F NIOJRGLZVLZTEC-UHFFFAOYSA-N 0.000 claims 1
- AHIRELMWVCASQN-UHFFFAOYSA-N 2-(aminomethyl)-6-[2-(3-fluorophenyl)ethynyl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C#CC1=CC(=CC=C1)F AHIRELMWVCASQN-UHFFFAOYSA-N 0.000 claims 1
- ANBKACSTTDONEG-UHFFFAOYSA-N 2-(aminomethyl)-6-[2-(4-fluorophenyl)ethynyl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C#CC1=CC=C(C=C1)F ANBKACSTTDONEG-UHFFFAOYSA-N 0.000 claims 1
- FGVJELXEWQXDEY-UHFFFAOYSA-N 2-(aminomethyl)-6-[2-(trifluoromethyl)pyrimidin-5-yl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC(=NC=1)C(F)(F)F FGVJELXEWQXDEY-UHFFFAOYSA-N 0.000 claims 1
- CWJSQUDIMGHXHN-UHFFFAOYSA-N 2-(aminomethyl)-6-[4-(trifluoromethyl)pyridin-3-yl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC=CC=1C(F)(F)F CWJSQUDIMGHXHN-UHFFFAOYSA-N 0.000 claims 1
- PBPGCYDYIQKUSY-UHFFFAOYSA-N 2-(aminomethyl)-6-[6-(trifluoromethyl)pyridin-3-yl]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC(=CC=1)C(F)(F)F PBPGCYDYIQKUSY-UHFFFAOYSA-N 0.000 claims 1
- KJFODOOLJRTEBN-UHFFFAOYSA-N 2-(aminomethyl)-6-[[1-(2-fluorophenyl)pyrazol-4-yl]amino]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC=1C=NN(C=1)C1=C(C=CC=C1)F KJFODOOLJRTEBN-UHFFFAOYSA-N 0.000 claims 1
- RROZANBHJLURSM-UHFFFAOYSA-N 2-(aminomethyl)-6-[[1-(3-fluorophenyl)pyrazol-4-yl]amino]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC=1C=NN(C=1)C1=CC(=CC=C1)F RROZANBHJLURSM-UHFFFAOYSA-N 0.000 claims 1
- YFAJVRSCFFOBNR-UHFFFAOYSA-N 2-(aminomethyl)-6-[[1-(4-fluorophenyl)pyrazol-4-yl]amino]-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC=1C=NN(C=1)C1=CC=C(C=C1)F YFAJVRSCFFOBNR-UHFFFAOYSA-N 0.000 claims 1
- DWXZSFACJKPGOK-UHFFFAOYSA-N 2-(aminomethyl)-6-anilino-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)NC1=CC=CC=C1 DWXZSFACJKPGOK-UHFFFAOYSA-N 0.000 claims 1
- NNUQBIURWFJXCE-UHFFFAOYSA-N 2-(aminomethyl)-6-bromo-1h-quinolin-4-one Chemical compound BrC1=CC=C2NC(CN)=CC(=O)C2=C1 NNUQBIURWFJXCE-UHFFFAOYSA-N 0.000 claims 1
- LILVBJMDXLZPBC-UHFFFAOYSA-N 2-(aminomethyl)-6-ethynyl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C#C LILVBJMDXLZPBC-UHFFFAOYSA-N 0.000 claims 1
- RRELQAKDUJUWPS-UHFFFAOYSA-N 2-(aminomethyl)-6-hydroxy-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)O RRELQAKDUJUWPS-UHFFFAOYSA-N 0.000 claims 1
- YZGHWMUPZUVDCE-UHFFFAOYSA-N 2-(aminomethyl)-6-methoxy-1h-quinolin-4-one Chemical compound N1C(CN)=CC(=O)C2=CC(OC)=CC=C21 YZGHWMUPZUVDCE-UHFFFAOYSA-N 0.000 claims 1
- UGXKKLWBMAUZLL-UHFFFAOYSA-N 2-(aminomethyl)-6-phenoxy-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OC1=CC=CC=C1 UGXKKLWBMAUZLL-UHFFFAOYSA-N 0.000 claims 1
- BJMXYBJUGHYLPA-UHFFFAOYSA-N 2-(aminomethyl)-6-phenyl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC=CC=C1 BJMXYBJUGHYLPA-UHFFFAOYSA-N 0.000 claims 1
- AJLZLCIWJZTMPT-UHFFFAOYSA-N 2-(aminomethyl)-6-phenylmethoxy-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC1=CC=CC=C1 AJLZLCIWJZTMPT-UHFFFAOYSA-N 0.000 claims 1
- FLDCDSRQDXVKKN-UHFFFAOYSA-N 2-(aminomethyl)-6-prop-2-ynoxy-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OCC#C FLDCDSRQDXVKKN-UHFFFAOYSA-N 0.000 claims 1
- IHXZTCALCBLFCZ-UHFFFAOYSA-N 2-(aminomethyl)-6-propan-2-yloxy-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)OC(C)C IHXZTCALCBLFCZ-UHFFFAOYSA-N 0.000 claims 1
- POOIGIHILGGFEF-UHFFFAOYSA-N 2-(aminomethyl)-6-pyrazin-2-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=NC=CN=C1 POOIGIHILGGFEF-UHFFFAOYSA-N 0.000 claims 1
- CGOKCTLKMJRXLC-UHFFFAOYSA-N 2-(aminomethyl)-6-pyrazol-1-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)N1N=CC=C1 CGOKCTLKMJRXLC-UHFFFAOYSA-N 0.000 claims 1
- KVOCLRIYUXEMHH-UHFFFAOYSA-N 2-(aminomethyl)-6-pyridin-2-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=NC=CC=C1 KVOCLRIYUXEMHH-UHFFFAOYSA-N 0.000 claims 1
- FMQQQQIWLJMWAP-UHFFFAOYSA-N 2-(aminomethyl)-6-pyridin-3-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC=CC=1 FMQQQQIWLJMWAP-UHFFFAOYSA-N 0.000 claims 1
- SEPYRMVJRNDMBE-UHFFFAOYSA-N 2-(aminomethyl)-6-pyridin-4-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=CC=NC=C1 SEPYRMVJRNDMBE-UHFFFAOYSA-N 0.000 claims 1
- HQCUSSYWHXYVSE-UHFFFAOYSA-N 2-(aminomethyl)-6-pyrimidin-5-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC=NC=1 HQCUSSYWHXYVSE-UHFFFAOYSA-N 0.000 claims 1
- TYZFONBTMUODEQ-UHFFFAOYSA-N 2-(aminomethyl)-6-quinolin-2-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C1=NC2=CC=CC=C2C=C1 TYZFONBTMUODEQ-UHFFFAOYSA-N 0.000 claims 1
- UQGKWPHKKGJYJB-UHFFFAOYSA-N 2-(aminomethyl)-6-quinolin-3-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=NC2=CC=CC=C2C=1 UQGKWPHKKGJYJB-UHFFFAOYSA-N 0.000 claims 1
- XBVIAVACAFQBQU-UHFFFAOYSA-N 2-(aminomethyl)-6-quinolin-8-yl-1H-quinolin-4-one Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C=1C=CC=C2C=CC=NC=12 XBVIAVACAFQBQU-UHFFFAOYSA-N 0.000 claims 1
- ZMGHVSWPPPHGHV-UHFFFAOYSA-N 2-(aminomethyl)-N-methyl-4-oxo-1H-quinoline-6-carboxamide Chemical compound NCC=1NC2=CC=C(C=C2C(C=1)=O)C(=O)NC ZMGHVSWPPPHGHV-UHFFFAOYSA-N 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000004404 heteroalkyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000003551 oxepanyl group Chemical group 0.000 claims 1
- 125000003566 oxetanyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000003386 piperidinyl group Chemical group 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000002098 pyridazinyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000005308 thiazepinyl group Chemical group S1N=C(C=CC=C1)* 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 125000002053 thietanyl group Chemical group 0.000 claims 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 claims 1
- 125000004306 triazinyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662293248P | 2016-02-09 | 2016-02-09 | |
| US62/293,248 | 2016-02-09 | ||
| PCT/US2017/016847 WO2017139274A1 (en) | 2016-02-09 | 2017-02-07 | Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019508400A JP2019508400A (ja) | 2019-03-28 |
| JP2019508400A5 true JP2019508400A5 (https=) | 2020-03-19 |
Family
ID=59564012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018540697A Ceased JP2019508400A (ja) | 2016-02-09 | 2017-02-07 | キノリノンリシルオキシダーゼ様２阻害剤とその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10588900B2 (https=) |
| EP (1) | EP3414229B1 (https=) |
| JP (1) | JP2019508400A (https=) |
| CN (1) | CN108884049A (https=) |
| AU (1) | AU2017218889A1 (https=) |
| CA (1) | CA3013917A1 (https=) |
| ES (1) | ES2880766T3 (https=) |
| WO (1) | WO2017139274A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016144702A1 (en) * | 2015-03-06 | 2016-09-15 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
| ES2880766T3 (es) | 2016-02-09 | 2021-11-25 | Pharmakea Inc | Inhibidores de quinolinona lisil oxidasa similar al tipo 2 y usos de los mismos |
| WO2018048928A1 (en) * | 2016-09-07 | 2018-03-15 | Pharmakea, Inc. | Chemical probes of lysyl oxidase-like 2 and uses thereof |
| JP7148769B2 (ja) * | 2017-09-12 | 2022-10-06 | 学校法人 工学院大学 | 複素環化合物又はその塩、ｇｐｒ３５作動薬及び医薬組成物 |
| GB201716871D0 (en) | 2017-10-13 | 2017-11-29 | Inst Of Cancer Research: Royal Cancer Hospital | Compounds |
| AU2020317374A1 (en) * | 2019-07-25 | 2022-02-03 | Pharmaxis Ltd. | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof |
| US12233056B2 (en) | 2022-04-06 | 2025-02-25 | Syntara Limited | Lysyl oxidase inhibitors for treating myeloid malignancies |
| AU2023317620A1 (en) | 2022-08-02 | 2025-02-13 | Basf Se | Pyrazolo pesticidal compounds |
| WO2024240859A1 (en) | 2023-05-25 | 2024-11-28 | Basf Se | Lactam pesticidal compounds |
| EP4467535A1 (en) | 2023-05-25 | 2024-11-27 | Basf Se | Lactam pesticidal compounds |
| WO2025256333A1 (en) | 2024-06-13 | 2025-12-18 | Syngenta Crop Protection Ag | Pesticidally active aminoheterocycle derivatives |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719102D0 (en) * | 1987-08-12 | 1987-09-16 | Merck Sharp & Dohme | Therapeutic agents |
| US5021456A (en) * | 1988-02-25 | 1991-06-04 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| TW274551B (https=) | 1991-04-16 | 1996-04-21 | Takeda Pharm Industry Co Ltd | |
| US5118499A (en) * | 1991-06-19 | 1992-06-02 | Spyros Theodoropulos | Quinoline polymers, their chelates and process of preparation and use |
| SG65570A1 (en) | 1992-02-25 | 1999-06-22 | Recordati Chem Pharm | Heterobicyclic compounds |
| US5474994A (en) | 1992-05-26 | 1995-12-12 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A |
| US5605896A (en) | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
| IT1254469B (it) | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
| EP0695753A1 (en) | 1994-08-05 | 1996-02-07 | Zeneca Limited | Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use |
| US5607928A (en) | 1994-08-05 | 1997-03-04 | Zeneca Limited | Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
| AU4153496A (en) | 1995-10-20 | 1997-05-07 | Flora Inc. | Transdermal delivery of alpha adrenoceptor blocking agents |
| GB0030729D0 (en) | 2000-12-16 | 2001-01-31 | Univ Nottingham | Substituted-4-Quinolones |
| CA2434066A1 (en) * | 2001-01-26 | 2002-09-12 | Pharmacia Italia S.P.A. | Chromane derivatives, process for their preparation and their use as antitumor agents |
| GB0116312D0 (en) | 2001-07-04 | 2001-08-29 | Univ Nottingham | "Compositions containing N-acyl homoserine lactones" |
| AU2003234733B2 (en) | 2002-04-17 | 2009-01-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US20050267120A1 (en) | 2004-04-14 | 2005-12-01 | Boehringer Ingelheim International Gmbh | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| DE102004056226A1 (de) * | 2004-11-22 | 2006-05-24 | Burchardt, Elmar Reinhold, Dr.Dr. | Neuartige Inhibitoren der Lysyloxidase |
| TWI391378B (zh) * | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
| EP2150544B1 (en) | 2007-03-19 | 2016-01-13 | Takeda Pharmaceutical Company Limited | Mapk/erk kinase inhibitors |
| JP5564947B2 (ja) * | 2007-09-26 | 2014-08-06 | アステラス製薬株式会社 | キノロン誘導体 |
| EP2262366A4 (en) * | 2008-04-18 | 2012-02-22 | Shenogen Pharma Group Ltd | COMPOUNDS AND METHODS FOR TREATING STROGEN RECEPTOR-RELATED DISEASES |
| JP2011231017A (ja) | 2008-09-09 | 2011-11-17 | Nissan Chem Ind Ltd | 光学活性エポキシ化合物及び光学活性スルホキシド化合物の製造方法、並びに該方法に用いる配位子、錯体及び該錯体の製造方法 |
| NZ592748A (en) | 2008-10-17 | 2013-01-25 | Akaal Pharma Pty Ltd | 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators |
| TWI492943B (zh) * | 2008-12-05 | 2015-07-21 | 大塚製藥股份有限公司 | 喹啉酮化合物及藥學組成物（二） |
| US8598354B2 (en) * | 2008-12-05 | 2013-12-03 | University Of South Florida | Compounds having antiparasitic or anti-infectious activity |
| WO2011050245A1 (en) | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
| PH12012500901A1 (en) | 2009-11-05 | 2016-08-05 | Rhizen Pharmaceuticals Sa | Novel benzopyran kinase modulators |
| EP3345915B1 (en) | 2010-04-12 | 2021-11-24 | Somalogic, Inc. | 5-position modified pyrimidines and their use |
| WO2012139045A1 (en) * | 2011-04-08 | 2012-10-11 | Gilead Biologics, Inc. | Methods and compositions for normalization of tumor vasculature by inhibition of loxl2 |
| AU2013255469B2 (en) | 2012-05-04 | 2017-10-12 | Rhizen Pharmaceuticals Sa | Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals |
| US9802949B2 (en) | 2012-11-29 | 2017-10-31 | Sunshine Lake Pharma Co., Ltd. | Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof |
| US9416139B2 (en) | 2012-11-29 | 2016-08-16 | Sunshine Lake Pharma Co., Ltd. | Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof |
| CN103848820A (zh) | 2012-11-29 | 2014-06-11 | 广东东阳光药业有限公司 | 作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用 |
| US9789096B2 (en) | 2013-09-04 | 2017-10-17 | Board Of Regents Of The University Of Texas System | Methods and compositions for selective and targeted cancer therapy |
| BR112016010165A2 (pt) | 2013-11-21 | 2017-12-05 | Somalogic Inc | composições de nucleotídeos modificados de citidina-5-carboxamida e métodos relacionados às mesmas |
| EP3129027A4 (en) | 2014-02-14 | 2017-06-21 | University of British Columbia | Modulators of caspase-6 |
| WO2016144702A1 (en) | 2015-03-06 | 2016-09-15 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
| EP3317258A4 (en) | 2015-07-01 | 2019-06-26 | Pharmakea, Inc. | LYSYL OXIDASE LIKE 2 INHIBITORS AND USES THEREOF |
| US20180215727A1 (en) * | 2015-07-23 | 2018-08-02 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
| ES2880766T3 (es) | 2016-02-09 | 2021-11-25 | Pharmakea Inc | Inhibidores de quinolinona lisil oxidasa similar al tipo 2 y usos de los mismos |
| WO2017197088A1 (en) * | 2016-05-12 | 2017-11-16 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors for the treatment of inflammatory conditions |
| WO2018048930A1 (en) | 2016-09-07 | 2018-03-15 | Pharmakea, Inc. | Lysyl oxidase-like 2 inhibitors and uses thereof |
| KR102615565B1 (ko) | 2016-09-07 | 2023-12-18 | 파마케아, 인크. | 리실 옥시다제 유사 2 억제제의 용도 |
| KR102587178B1 (ko) * | 2016-09-07 | 2023-10-06 | 파마케아, 인크. | 리실 옥시다아제-유사 2 억제제의 결정질 형태 및 제조 방법 |
| WO2018048928A1 (en) | 2016-09-07 | 2018-03-15 | Pharmakea, Inc. | Chemical probes of lysyl oxidase-like 2 and uses thereof |
-
2017
- 2017-02-07 ES ES17750636T patent/ES2880766T3/es active Active
- 2017-02-07 CN CN201780022652.7A patent/CN108884049A/zh active Pending
- 2017-02-07 CA CA3013917A patent/CA3013917A1/en active Pending
- 2017-02-07 EP EP17750636.7A patent/EP3414229B1/en active Active
- 2017-02-07 JP JP2018540697A patent/JP2019508400A/ja not_active Ceased
- 2017-02-07 WO PCT/US2017/016847 patent/WO2017139274A1/en not_active Ceased
- 2017-02-07 US US16/076,621 patent/US10588900B2/en active Active
- 2017-02-07 AU AU2017218889A patent/AU2017218889A1/en not_active Abandoned
-
2019
- 2019-08-27 US US16/553,042 patent/US11058676B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508400A5 (https=) | ||
| JP2015503571A5 (https=) | ||
| JP2017075193A5 (https=) | ||
| JP2016523976A5 (https=) | ||
| JP2018512381A5 (https=) | ||
| JP2007510689A5 (https=) | ||
| JP2016522232A5 (https=) | ||
| JP2021502356A5 (https=) | ||
| HRP20160539T1 (hr) | Antagonisti trpv4 | |
| US20080153811A1 (en) | Methods of Treating Cognitive Impairment and Dementia | |
| JP2016523935A5 (https=) | ||
| RU2006112046A (ru) | Производные пиррола с антибактериальным действием | |
| RU2017105296A (ru) | Новые соединения | |
| JP2014518214A5 (https=) | ||
| JP2010524970A5 (https=) | ||
| JP2018510183A5 (https=) | ||
| JP2019504821A5 (https=) | ||
| JP2013523884A5 (https=) | ||
| RU2005123484A (ru) | Новые производные пиридазин-3(2н)-она | |
| IL263511A (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| HRP20200575T1 (hr) | Spojevi karbamata i postupci pripremanja i korištenja istih | |
| JP2012525349A5 (https=) | ||
| JP2016512511A5 (https=) | ||
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| US11660301B2 (en) | Combination of ATR kinase inhibitors with PARP inhibitors |